Latest News and Press Releases

PharmAla incorporates a new entity in Australia to take advantage of tax incentives, and appoints Dr. Evan Lewis to its clinical advisory board.

PharmAla provides corporate update following AGM

PharmAla recieves a non-dilutive grant from IP Ontario (IPON) to support its patent work in international markets.

PharmAla granted a Health Canada Controlled Drugs and Substances Dealer's License